Cerner, Livongo Team Up on Connected Diabetes Care
Electronic health records vendor Cerner has announced a multi-year agreement with remote care platform developer Livongo Health to connect diabetes screening data collected from smart consumer devices with Cerners healthcare clients.
Electronic health records vendor Cerner has announced a multi-year agreement with remote care platform developer Livongo Health to connect diabetes screening data collected from smart consumer devices with Cerners healthcare clients.
"For people with diabetes, this can mean more effective self-management and a better use of time with their clinician," the companies said in announcing the deal. "For care teams, this provides near real-time access to patient information, enabling quick interventions when a patient might be headed toward trouble."
Cerner executives said the relationship is the latest advancement in Cerners broad population health strategy to foster greater consumer and clinical device connectivity inside and out of care facilities.
While the traditional diabetes care model relies heavily on in-clinic monitoring and direct physician interaction, the Livongo device remotely transmits the information to a smart cloud for analysis. Actionable information is then quickly returned to the individual and members of their care team.
Patients use Livongos cellular-enabled blood glucose meter to measure their blood glucose levels, which are then automatically sent to the individuals theyve designated, including physicians, family members, care coordinators, population health managers, or other members of their care team. The device also passively collects information on activity and records behavioral information. Once the information is shared, that persons care team can provide support if values are outside of their normal range.
This is the right program at the right time to empower our clients and their patients with the real-time information they need to help effectively manage and improve their health, said Zane Burke, president of Cerner. It fits perfectly with our vision for population health, which is to provide clarity to millions of data points in an actionable and timely way to improve health and care outcomes across the population.
"For people with diabetes, this can mean more effective self-management and a better use of time with their clinician," the companies said in announcing the deal. "For care teams, this provides near real-time access to patient information, enabling quick interventions when a patient might be headed toward trouble."
Cerner executives said the relationship is the latest advancement in Cerners broad population health strategy to foster greater consumer and clinical device connectivity inside and out of care facilities.
While the traditional diabetes care model relies heavily on in-clinic monitoring and direct physician interaction, the Livongo device remotely transmits the information to a smart cloud for analysis. Actionable information is then quickly returned to the individual and members of their care team.
Patients use Livongos cellular-enabled blood glucose meter to measure their blood glucose levels, which are then automatically sent to the individuals theyve designated, including physicians, family members, care coordinators, population health managers, or other members of their care team. The device also passively collects information on activity and records behavioral information. Once the information is shared, that persons care team can provide support if values are outside of their normal range.
This is the right program at the right time to empower our clients and their patients with the real-time information they need to help effectively manage and improve their health, said Zane Burke, president of Cerner. It fits perfectly with our vision for population health, which is to provide clarity to millions of data points in an actionable and timely way to improve health and care outcomes across the population.
More for you
Loading data for hdm_tax_topic #better-outcomes...